[Glucose homeostasis. II. Homeostasis disturbances--hypoglycemia in newborns and infants]

E Otto Buczkowska1, P Jarosz Chobot, G Szirer

  • 1Ośrodek Diabetologiczny Dzieci i Młodziezy w Gliwicach. em.buczkowski@pro.onet.pl

Przeglad Lekarski
|July 31, 2001
PubMed

Insights

Hypoglycaemia, or low blood sugar, requires prompt attention. Identifying the cause, especially in newborns, is crucial to prevent neurological damage.

Area of Science:

  • Pediatrics
  • Neonatology
  • Endocrinology

Context:

  • Glucose is essential for brain function, making hypoglycemia a critical concern.
  • Neonatal hypoglycemia, if prolonged or recurrent, can lead to preventable neurological deficits.
  • Accurate etiological diagnosis is challenging but vital for effective management.

Purpose:

  • To outline the causes of neonatal hypoglycemia.
  • To differentiate between transient and persistent hypoglycemia.
  • To categorize causes based on impaired glucose production or increased utilization.

Summary:

  • Neonatal hypoglycemia can stem from decreased hepatic glucose production or increased peripheral glucose utilization.
  • This article focuses on the initial categories of causes for hypoglycemia in newborns.
  • Understanding these causes is the first step in preventing long-term developmental issues.

Impact:

  • Facilitates timely and accurate diagnosis of neonatal hypoglycemia.
  • Aids pediatricians in preventing severe neurological consequences.
  • Contributes to improved management strategies for affected infants.

Related Concept Videos

Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...